STOCK TITAN

Cadre Holdings (NYSE: CDRE) CEO updates stake after RSU vesting and tax withholding

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cadre Holdings CEO Warren B. Kanders reported routine equity compensation activity. On March 18, 2026, 11,180 restricted stock units granted in 2024 converted into an equal number of Cadre Holdings common shares. To cover tax obligations from this vesting, 4,400 common shares were withheld by the company at a price of $32.22 per share.

Following these transactions, Kanders holds 22,888 shares of common stock directly. He also reports additional indirect holdings, including shares held by Kanders SAF, LLC and by Roth IRAs for himself and his spouse, while disclaiming beneficial ownership except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KANDERS WARREN B

(Last)(First)(Middle)
C/O KANDERS & COMPANY, INC.
250 ROYAL PALM WAY, SUITE 201

(Street)
PALM BEACH FLORIDA 33480

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
CEO AND CHAIRMAN
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.0001 per share ("Common Stock")03/18/2026M11,180A(1)27,288D
Common Stock03/18/2026F4,400(2)D$32.2222,888D
Common Stock10,117,039IBy Kanders SAF, LLC(3)(5)
Common Stock1,305,650IBy Warren B. Kanders Roth IRA
Common Stock23,450IBy Allison Kanders Roth IRA(4)(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)03/18/2026M11,180 (1) (1)Common Stock11,180$011,180D
Explanation of Responses:
1. Comprised of a restricted stock units award granted on March 18, 2024 (the "2024 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 33,540 shares of Common Stock. Of those shares, 11,180 shares vested and became non-forfeitable on each of March 18, 2025 and March 18, 2026, and 11,180 shares will vest and become non-forfeitable on March 18, 2027.
2. Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Kanders as a result of the vesting, on March 18, 2026, of a portion of the 2024 Restricted Stock Award.
3. The Reporting Person is the sole manager and member of Kanders SAF, LLC.
4. Allison Kanders is the Reporting Person's spouse.
5. The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.
/s/ Warren B. Kanders03/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Cadre Holdings (CDRE) CEO Warren B. Kanders report in this Form 4?

Warren B. Kanders reported vesting of 11,180 restricted stock units that converted into Cadre Holdings common shares. The filing also shows shares withheld to pay taxes and updates his direct and indirect ownership positions.

How many Cadre Holdings (CDRE) shares did Warren B. Kanders receive from vesting RSUs?

Kanders had 11,180 restricted stock units vest and convert into 11,180 Cadre Holdings common shares. These units were part of a 2024 award covering 33,540 shares, vesting in three equal annual installments.

Were any Cadre Holdings (CDRE) shares sold by Warren B. Kanders in this Form 4?

The filing shows 4,400 Cadre Holdings common shares were withheld at $32.22 per share to satisfy tax obligations from RSU vesting. This tax-withholding disposition is not an open-market sale and reflects routine handling of equity compensation taxes.

What is Warren B. Kanders’ direct Cadre Holdings (CDRE) ownership after these transactions?

After the RSU vesting and tax withholding, Kanders directly holds 22,888 Cadre Holdings common shares. This figure reflects his updated personal position, separate from the larger indirect holdings reported through entities and retirement accounts.

What indirect holdings in Cadre Holdings (CDRE) are associated with Warren B. Kanders?

Indirect holdings include 10,117,039 Cadre Holdings common shares held by Kanders SAF, LLC, 1,305,650 shares in his Roth IRA, and 23,450 shares in his spouse’s Roth IRA. He disclaims beneficial ownership except to the extent of his pecuniary interest.

Is this Cadre Holdings (CDRE) Form 4 a routine equity compensation event?

Yes. The transactions reflect scheduled vesting of a 2024 restricted stock unit award and related tax-withholding shares. No open-market purchases or sales are reported, making this a routine compensation and ownership update for the CEO and chairman.
Cadre Hldgs Inc

NYSE:CDRE

View CDRE Stock Overview

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.37B
29.04M
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE